Some individuals experience side effects like nausea or digestive discomfort Results vary depending on lifestyle and metabolic health Long-term dependency and sustainability are still being studied And importantly, it does not replace foundational health habits
Acting like ghrelin, ipamorelin stimulates the release of growth hormone-releasing hormone and reduces the release of somatostatin
Studies have shown that maintaining a normal level of cyanocobalamin in the blood leads to a reduction in homocysteine levels, thus contributing to slower aging of the brain
While GLP-1 jabs have been shown in randomised controlled trials lead to weight loss of 15 to 20%, around half of all patients discontinue their use within the first year, with three-quarters stopping after two years
The perceived energy boost reported by non-deficient individuals is likely attributable to placebo effect
Metabolic Benefits That Persist Over Time One of the most important findings from long term studies is that metabolic improvements continue as long as people remain on GLP-1 therapy